Oren Gilad, President/CEO at Aprea Therapeutics, Inc. (APRE), bought 28,100 shares at $0.89 ($25K) on 2026-01-30, disclosed to the SEC on 2026-02-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| APRE | BUY | 2024-10-16 | $725 | — | Filing → |
| APRE | BUY | 2024-10-15 | $3K | — | Filing → |
| APRE | BUY | 2024-03-14 | $15K | — | Filing → |